文献速递血栓与止血

性别差异:治疗年轻女性静脉血栓栓塞症时的5P实践

Sex matters: Practice 5P's when treating young women with venous thromboembolism.
PubMed 文献 · J Thromb Haemost · 2019-07-23

本文提出与年轻女性静脉血栓栓塞症(VTE)患者讨论的5P要点:月经期、口服避孕药、预后、妊娠和血栓后综合征。月经期失血可被抗凝治疗加重,尤其直接口服抗凝药;异常子宫出血可用激素治疗、氨甲环酸或调整治疗管理。联合口服避孕药是VTE危险因素,风险大小取决于孕激素类型和雌激素剂量。

要点

  • 月经期失血可被抗凝治疗加重,尤其直接口服抗凝药。
  • 异常子宫出血可用激素治疗、氨甲环酸或调整治疗管理。
  • 联合口服避孕药是VTE危险因素,风险取决于孕激素类型和雌激素剂量。

核心结论

  • VTE管理需关注年轻女性特有的5P问题:月经期、口服避孕药、预后、妊娠和血栓后综合征。

研究设计与样本

  • 原文未报告研究设计;本文为针对年轻女性VTE治疗的综述性文章,提出5P框架。

主要发现

  • 月经期失血可被抗凝治疗加重,尤其直接口服抗凝药。
  • 异常子宫出血可用激素治疗、氨甲环酸或调整治疗管理。
  • 联合口服避孕药是VTE危险因素,风险大小取决于孕激素类型和雌激素剂量。
  • 使用治疗性抗凝的女性中,同时激素治疗不增加复发性VTE风险。
  • 左炔诺孕酮释放宫内装置和低剂量孕激素-only片不增加VTE风险。

关键数值与推荐

  • 妊娠使VTE风险增加4-5倍。
  • 血栓倾向和产科危险因素进一步增加妊娠相关VTE风险。
  • 有VTE史的妇女中,妊娠或产后复发风险似乎受首次VTE时存在的危险因素影响。
  • 多数有VTE史的妇女,产前和产后指示使用低分子肝素血栓预防。

临床怎么用

  • 与年轻女性VTE患者讨论月经期、口服避孕药、预后、妊娠和血栓后综合征。
  • 异常子宫出血可考虑激素治疗、氨甲环酸或调整抗凝治疗。
  • 使用治疗性抗凝时,同时激素治疗不增加复发性VTE风险。
  • 左炔诺孕酮释放宫内装置和低剂量孕激素-only片不增加VTE风险。
  • 多数有VTE史的妇女,产前和产后使用低分子肝素血栓预防。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sex matters when it comes to venous thromboembolism (VTE). We defined 5P's - period, pill, prognosis, pregnancy, and postthrombotic syndrome - that should be discussed with young women with VTE. Menstrual blood loss (Period) can be aggravated by anticoagulant therapy. This seems particularly true for direct oral anticoagulants. Abnormal uterine bleeding can be managed by hormonal therapy, tranexamic acid, or modification of treatment. The use of combined oral contraceptives (Pill) is a risk factor for VTE. The magnitude of the risk depends on progestagen types and estrogen doses used. In women using therapeutic anticoagulation, concomitant hormonal therapy does not increase the risk of recurrent VTE. Levonorgestrel-releasing intrauterine devices and low-dose progestin-only pills do not increase the risk of VTE. In young women VTE is often provoked by transient hormonal risk factors that affects prognosis. Sex is incorporated as predictor in recurrent VTE risk assessment models. However, current guidelines do not propose using these to guide treatment duration. Pregnancy increases the risk of VTE by 4-fold to 5-fold. Thrombophilia and obstetric risk factors further increase the risk of pregnancy-related VTE. In women with a history of VTE, the risk of recurrence during pregnancy or post partum appears to be influenced by risk factors present during the first VTE. In most women with a history of VTE, antepartum and postpartum thromboprophylaxis with low-molecular-weight heparin is indicated. Women generally are affected by VTE at a younger age then men, and they have to deal with long-term complications (Post-thrombotic syndrome) of deep vein thrombosis early in life.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Bistervels IM, Scheres LJJ, Hamulyák EN, et al. Sex matters: Practice 5P's when treating young women with venous thromboembolism. J Thromb Haemost. 2019. PMID: 31220399. doi:10.1111/jth.14549

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。